Kimia Biosciences Ltd receives DMF approval from Korea

Kimia Biosciences Ltd has received DMF approval of Fimasartan Potassium Trihydrate, Active Pharmaceutical Ingredients (API) from Korea.

Shares of Kimia Biosciences Ltd was last trading in BSE at Rs. 41.60 as compared to the previous close of Rs. 38.70. The total number of shares traded during the day was 11167 in over 88 trades.

The stock hit an intraday high of Rs. 42.00 and intraday low of 38.20. The net turnover during the day was Rs. 456961.00.

Source : Equity Bulls

Keywords

KimiaBiosciences INE285U01025 API DMFApproval FimasartnaPotassiumTrihydrate Korea